Journals / Haydarpaşa Numune Eğitim ve Araştırma Hastanesi Tıp Dergisi / 2016 / Cilt: 56 - Sayı: 1

Adenomyosis Incidence in Hysterectomy Materials

HİSTEREKTOMİ MATERYALLERİNDE ADENOMYOZİS SIKLIĞININ ARAŞTIRILMASI

Pages
23–27
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Adenomyosis must be remembered in mind in patients admitted to clinic due to different causes and before managing treatment.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To determine the frequency of adenomyosis in hystrectomy materials.Materials and Methods: We here in analyse the adenomyozis frequency in histopathologic evaluation of 255 hysterectomy materials performed due to bening causes in Bakırköy Dr Sadi Konuk Hospital Obstetric and Gynecology Clinic and demographic properties of these patients are evaluated.
📊
Key Findings & Data:Results: 255 hysterectomy materials are evaluated in this study and 48 adenomyosis (%19.2) case are determined.
💡
Conclusion & Impact:Conclusion: Adenomyosis must be remembered in mind in patients admitted to clinic due to different causes and before managing treatment.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: To determine the frequency of adenomyosis in hystrectomy materials.Materials and Methods: We here in analyse the adenomyozis frequency in histopathologic evaluation of 255 hysterectomy materials performed due to bening causes in Bakırköy Dr Sadi Konuk Hospital Obstetric and Gynecology Clinic and demographic properties of these patients are evaluated. Results: 255 hysterectomy materials are evaluated in this study and 48 adenomyosis (%19.2) case are determined. Conclusion: Adenomyosis must be remembered in mind in patients admitted to clinic due to different causes and before managing treatment.

Özet

Amaç: Histerektomi materyallerinde adenomyozis sıklığının saptanması amaçlanmıştır. Gereç ve Yöntemler: Çalışmamızda Bakırköy DrSadi Konuk Hastanesi Kadın Hastalıkları ve Doğum Kliniği'nde benign nedenlerle histerektomi yapılan 255 hastanın postoperatif histerektomi materyallerinin histopatolojik değerlendirmelerinde adenomyozis sıklığı ve bu vakaların demografik özellikleri incelendi. Bulgular: Bu çalışmada toplam 255 histerektomi materyali incelendi ve 48 tanesinde (%19,2) adenomyozis varlığı tespit edildi. Sonuç: Adenomyozis tanısı, değişik nedenlerle kliniğe başvuran hastalarda tedavi planlaması esnasında akılda tutulmalıdır

🔖

Cite This Article

AVCI, E., KABAN, I., EKİN, M., CENGİZ, H. (2022). Adenomyosis Incidence in Hysterectomy Materials. Haydarpaşa Numune Eğitim ve Araştırma Hastanesi Tıp Dergisi, Cilt: 56 - Sayı: 1, 23–27. https://ajindex.com/articles/535298

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Zaloudek C, Hendrickson MR. Mesenchymal tumors of the uterus. In Blausteins' pathology of thefemalegeni- taltract. Kurman RJ ed. Fifthedition, New York: Sprin- ger, 2002: 561- 573. Bergholt T. Prevalenceand risk factors of adenomyosis at hysterectomy. Hum Reprod. 2001 Nov;16(11):2418- 21. Ferenczy A. Pathophysiology of adenomyosis. Hum Reprod Update. 1998; 4: 312-22. Pernoll ML. Obstetrik ve Jinekoloji El Kitabı. Ayhan A (Çeviren). 10. baskı, Ankara: Palme, 2002: 755-767.
  2. GersonWeiss, M.D., Adenomyosis a variant, not a disease? Evidencefrom hysterectomizedmenopau salwomen in theStudy of Women'sHealthAcrosstheNa tion (SWAN). Fertil Steril. 2009 Jan;91(1):201-6. doi: 1016/j.fertnstert.2007.11.025. Epub 2008 Feb 20. Atri M, Reinhold C, Mehio AR, Chapman WB, Bret PM. Adenomyozis: US features withhistologiccorrelation in an in vitrostudy. Radiology. 2000; 215: 783-790.
  3. Shrestha A, Adenomyosis at hysterectomy: prevalence, patientcharacteristics, clinical profile andhistopatholgi- calfindings. KathmanduUnivMed J (KUMJ). 2012 Jan- Mar;10(37):53-6.
  4. Wood C, Maher P, Hill D. Biopsydiagnosisandconserva tivesurgicaltreatment of adenomyosis. Aust N Z J Obs- tetGynaecol, 1993; 33: 319-321.
  5. Fong YF, Singh K. Medicaltreatment of a grosslyenlar- gedadenomyoticuteruswith thelevonorgestrelreleasin- gintrauterinesystem. Contraception, 1999; 60: 173-175.
  6. Sheng J, Zhang WY, Zhang JP, Lu D. The LNG-IUS study on adenomyosis: a 3-year follow-upstudy on theeffica- cyandsideeffects of theuse of levonorgestrelintrauterine systemforthetreatment of dysmenorrheaassociatedwit- hadenomyosis. Contraception, 2009; 79: 189-193.
  7. Igarashi M, Abe Y, Fukuda M, Ando A, Miyasaka M, Yoshida M. Novelconservative medicaltherapyforuteri- neadenomyosiswith a danazolloadedintrauterinedevice. Fertil Steril, 2000; 74: 412-413. Shawki OA. Danazolloadedintrauterinedevice D-IUD: a novelconservative managementforuterineadenomyosis. Middle East FertilitySocietyJournal. 2002; 7: 214- 220. Huang WS, Ynag TS, Yuan CC. Successfulpregnancyaf- tertreatment of deep adenomyosiswithcytoreductive- surgeryandsubsequentgonadotropin-releasinghormone agonist: a casereport. ChinMed J. 1998; 61: 726-729.
  8. Lin J, Sun C, Zheng H. Gonadotropinreleasinghormone- agonistsandlaparoscopy in thetreatment of adenomyo- sisandinfertility. ChinMed J. 2000; 113: 442-445.
  9. Pelage JP, Jacob D, Fazel A, et al. Midtermresults of uterinearteryembolizationfor symptomaticadenomyo- sis: initialexperience. Radiology 2005; 234:948. Rabinovici J, In